Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U85191KA2012PTC065703 Incorporated 03 September 2012 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2017
₹5.48 Cr
▲ 73% YoY
Net loss · FY 2017
₹2.72 Cr
Net margin -49.6%
EBITDA · FY 2017
-₹2.29 Cr
EBITDA margin -41.8%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹10.9 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Employees · EPFO
1
Provident fund records

About Emdrix Pharmaceuticals Private Limited

Data last updated:

Emdrix Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 03 September 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85191KA2012PTC065703. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹10.9 Lakh. It is led by directors including Namitha Ananth (Whole-Time Director) and Subbaraju Ananth Narasimha (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2017, the company reported a revenue of ₹5.48 Cr, a growth of 73% compared to the previous year. For the same year it recorded a net loss of ₹2.72 Cr (net margin -49.6%) and EBITDA of -₹2.29 Cr (EBITDA margin -41.8%).

The company has about 1 employee on its provident fund (EPFO) records.

The company is associated with 1 brand: Emdrix Pharmaceuticals. As per MCA filings, the company has open charges of ₹2 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website emdrix.com.

Company Details of Emdrix Pharmaceuticals Private Limited
CIN U85191KA2012PTC065703
Registration Number 065703
Incorporation Date 03 September 2012
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2017
Date of Balance Sheet 31 March 2017
Compliance Status Active Non-Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    No.100 Gokaram Tower 4th Floor Portion – A 1st Ma In 5th Cross New Timber Yard Layout M, Ysore Road, Bangalore, Karnataka, India – 560026
  • Industry
    Healthcare, Medical Equipment Retail & Distribution
Comprehensive company report
Emdrix Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Emdrix Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Emdrix Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals operates one associated brand: Emdrix Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Provides drug research, development, and formulation services for the pharmaceutical sector.emdrix.com

Competitors & Alternatives of Emdrix Pharmaceuticals Private Limited

Brands and companies operating in the same space as Emdrix Pharmaceuticals Private Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.

CompetitorDescriptionLocationFounded
WuXi AppTec WuXi AppTec Provider of CRO and CDMO servicesShanghai, China2000
ANI Pharmaceuticals ANI Pharmaceuticals Branded and generic prescription drugs are developed, manufactured, and marketed.Baudette, United States1996
Aptar Aptar Regulatory support, brand differentiation, and prototyping services are provided.Crystal Lake, United States1992
CHEPLAPHARM CHEPLAPHARM Branded pharmaceutical products are developed, marketed, and distributed globally.Mesekenhagen, Germany1998
Red Nucleus Red Nucleus Advisory, scientific, and medical communications provided for pharmaceutical industry.Yardley, United States2014
Ipsen Ipsen Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes1929
Eurofins Scientific Eurofins Scientific Laboratory testing and contract research services are provided globally.Luxembourg1987
China Medical System China Medical System Generic formulations including tablets, capsules, liquids, and injectables are manufactured.Shenzhen, China1992
Aliada Therapeutics Aliada Therapeutics Provider of drug research & development services for multiple therapeutic areasBoston, United States2021

Business Activity of Emdrix Pharmaceuticals Private Limited

The main business activity of Emdrix Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals Private Limited is audited by TILOK CHAND & CO for the financial year 2017.

NameStatusAppointment DateCessation Date
TILOK CHAND & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Niranjan Surendra ShettyDirector16 Jul 201610 Years 2 MonthsCurrent
Namitha AnanthWhole-Time Director03 Sep 201214 Years 1 MonthsCurrent
Subbaraju Ananth NarasimhaWhole-Time Director03 Sep 201214 Years 1 MonthsCurrent
SharmarashmiWhole-Time Director03 Sep 201214 Years 1 MonthsCurrent
Hindupur Narasingarao UdayasimhaWhole-Time Director03 Sep 201214 Years 1 MonthsCurrent

Financials of Emdrix Pharmaceuticals Private Limited FY 2017 filings available

Emdrix Pharmaceuticals Private Limited reported revenue of ₹5.48 Cr (up 73% YoY) for FY 2017.

Revenue · FY 2017
₹5.48 Cr ▲ 73%
Net loss · FY 2017
₹2.72 Cr margin -49.6%
EBITDA · FY 2017
-₹2.29 Cr margin -41.8%

Compounded Annual Growth Rate (CAGR) of Emdrix Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 73%
EBITDA CAGR growth
1 year
▼ 619%

Revenue rose 73% in the latest year. EBITDA fell 619% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Emdrix Pharmaceuticals Private Limited

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹5.48 Cr••••••••
Other Income••••••••••••
Total Revenue••••••••••••
Cost of Materials Consumed••••••••••••
Employee Benefit Expense••••••••••••
Finance Costs••••••••••••
Depreciation and Amortisation••••••••••••
Other Expenses••••••••••••
Total Expenses••••••••••••
EBITDA-₹2.29 Cr••••••••
Profit Before Tax••••••••••••
Tax Expense••••••••••••
Net Profit (PAT)-₹2.72 Cr••••••••
Balance Sheet
Share Capital••••••••••••
Reserves and Surplus••••••••••••
Net Worth (Total Equity)••••••••••••
Long-term Borrowings••••••••••••
Short-term Borrowings••••••••••••
Trade Payables••••••••••••
Total Liabilities••••••••••••
Fixed Assets••••••••••••
Investments••••••••••••
Inventories••••••••••••
Trade Receivables••••••••••••
Cash and Bank Balance••••••••••••
Total Assets••••••••••••

Financial Ratios of Emdrix Pharmaceuticals Private Limited

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-41.8%••••••••
Net Profit Margin-49.6%••••••••
Return on Equity (ROE)••••••••••••
Return on Capital Employed (ROCE)••••••••••••
Return on Assets (ROA)••••••••••••
Liquidity and Debt
Current Ratio••••••••••••
Quick Ratio••••••••••••
Debt-to-Equity Ratio••••••••••••
Interest Coverage Ratio••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••
Receivable Days••••••••••••
Payable Days••••••••••••
Inventory Days••••••••••••
Revenue Growth••••••••••••
Net Profit Growth••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emdrix Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Emdrix Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Emdrix Pharmaceuticals Private Limited

Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of Mysore₹2.00 Cr
Latest charge details
DateLenderAmountStatus
26 May 2015State Bank of Mysore₹2 CrOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals Private Limited has a workforce of 1 employees as of Apr 07, 2024.

Employee count
1
Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Emdrix Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Emdrix Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Emdrix Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Emdrix Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Emdrix Pharmaceuticals Private Limited

Activity
30 Sep 2017
Emdrix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records.
Activity
31 Mar 2017
Emdrix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Bangalore.
Directors
16 Jul 2016
Niranjan Surendra Shetty was appointed as a Director on 16 Jul 2016 & has been associated with this company since 10 years 2 months.
Charges
26 May 2015
A charge with State Bank Of Mysore amounted to Rs. 200.00 Lakh with Charge ID 10574477 was registered on 26 May 2015.
Directors
03 Sep 2012
Namitha Ananth was appointed as a Whole-time director on 03 Sep 2012 & has been associated with this company since 14 years 1 month.
Directors
03 Sep 2012
Subbaraju Ananth Narasimha was appointed as a Whole-time director on 03 Sep 2012 & has been associated with this company since 14 years 1 month.

Frequently Asked Questions about Emdrix Pharmaceuticals Private Limited

Emdrix Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 03 September 2012 (14+ years old) and is registered under CIN U85191KA2012PTC065703.

Emdrix Pharmaceuticals reported revenue of ₹5.48 Cr for FY 2017 (up 73% YoY).

Emdrix Pharmaceuticals has 5 current directors:

Emdrix Pharmaceuticals reported a net loss of ₹2.72 Cr (net margin -49.6%) and EBITDA of -₹2.29 Cr (EBITDA margin -41.8%) for FY 2017, as per its filed financial statements.

No. Emdrix Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Emdrix Pharmaceuticals is U85191KA2012PTC065703. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Emdrix Pharmaceuticals has 1 court case on record: 1 filed by the company.

Emdrix Pharmaceuticals was incorporated on 03 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.

Emdrix Pharmaceuticals can be reached through the website emdrix.com. Its registered office is in Bangalore, Karnataka, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available